invasive breast cancer
Showing 1 - 25 of 63
Invasive Breast Cancer, Inflammatory Breast Cancer Stage III, HER2-positive Breast Cancer Trial in Boston (Trastuzumab
Not yet recruiting
- Invasive Breast Cancer
- +4 more
- Trastuzumab deruxtecan
- Durvalumab
-
Boston, Massachusetts
- +1 more
Mar 20, 2023
Development of Multi-specific Antibodies Based on Immune
Not yet recruiting
- Invasive Breast Cancer
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Mar 2, 2023
Breast Cancer, Invasive Breast Cancer Trial in New York (diagnostic test, radiation, procedure)
Recruiting
- Breast Cancer
- Invasive Breast Cancer
- Pre-neoadjuvant radiotherapy (NART) biopsy
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Jan 31, 2023
Infiltrating Duct Carcinoma of the Breast
Not yet recruiting
- Invasive Breast Cancer
- (no location specified)
Jan 28, 2023
Microbiome on Breast Cancer Radiotherapy Toxicity
Recruiting
- DCIS
- Invasive Breast Cancer
- Stool sample
- Skin Swab Sample
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
Jan 30, 2023
Invasive Breast Cancer Trial in Cleveland (Smart Goggle, Cardio-Green, SPY Elite Imaging system)
Suspended
- Invasive Breast Cancer
- Smart Goggle
- +6 more
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
Jan 5, 2023
Triple Negative Breast Cancer, Stage IV Breast Cancer, HER2 Negative Trial in United States (Atezolizumab, Carboplatin,
Active, not recruiting
- Triple Negative Breast Cancer
- +3 more
- Atezolizumab
- +3 more
-
Washington, District of Columbia
- +5 more
Dec 1, 2022
Invasive Breast Cancer, Metastatic Breast Cancer, HR-Positive Breast Cancer Trial in United States (Pembrolizumab, Sacituzumab
Recruiting
- Invasive Breast Cancer
- +3 more
- Pembrolizumab
- Sacituzumab Govitecan
-
Atlanta, Georgia
- +7 more
Nov 14, 2022
Ductal Breast Carcinoma in Situ, Invasive Breast Cancer, Early-stage Breast Cancer Trial in Mérida (Hypofractionated
Recruiting
- Ductal Breast Carcinoma in Situ
- +6 more
- Hypofractionated radiotherapy
-
Mérida, Yucatán, MexicoUnidad Medica de Alta Especialidad
Nov 7, 2022
Breast Cancer, Invasive Breast Cancer, in Situ Breast Cancer Trial in Boston (Standard Genetic Counseling, Quantitative Genetic
Recruiting
- Breast Cancer
- +3 more
- Standard Genetic Counseling
- Quantitative Genetic Counseling
-
Boston, MassachusettsDana Farber Cancer Institute
Sep 26, 2022
Early-stage Breast Cancer, Hormone Receptor Positive Breast Carcinoma, Invasive Breast Cancer Trial in United States (drug,
Recruiting
- Early-stage Breast Cancer
- +6 more
- Anastrozole
- +2 more
-
Fullerton, California
- +8 more
Sep 19, 2022
Breast Cancer, Breast Cancer Female, Breast Cancer, Male Trial in Tampa (biological, drug, procedure)
Recruiting
- Breast Cancer
- +7 more
- Dendritic Cell Vaccine (DC1)
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Aug 23, 2022
Invasive Breast Cancer, Post-mastectomy Trial in New York (Radiotherapy)
Recruiting
- Invasive Breast Cancer
- Post-mastectomy
- Radiotherapy
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Aug 17, 2022
Breast Cancer, Ductal Carcinoma in Situ, Invasive Breast Cancer Trial in Milwaukee (Deep Inspiration Breath Hold during
Completed
- Breast Cancer
- +2 more
- Deep Inspiration Breath Hold during Radiation
- Free breathing during radiation
-
Milwaukee, WisconsinFroedtert Hospital and Medical College of Wisconsin
Aug 1, 2022
Invasive Breast Cancer, Ipsilateral Recurrence, Sentinel Lymph Node Biopsy Trial in France (Sentinel LN in breast cancer
Terminated
- Invasive Breast Cancer
- +2 more
- Sentinel LN in breast cancer recurrence
-
Bordeaux, France
- +8 more
Apr 19, 2022
Invasive Breast Cancer Trial in Milwaukee (Cemiplimab, Paclitaxel, Carboplatin (not mandatory))
Recruiting
- Invasive Breast Cancer
- Cemiplimab
- +4 more
-
Milwaukee, WisconsinFroedtert Hospital & Medical College of Wisconsin
Apr 1, 2022
Carcinoma, Ductal, Breast, Invasive Breast Cancer, IMAGE Trial in Seoul (contrast-enhanced breast MRI)
Completed
- Carcinoma, Ductal, Breast
- +2 more
- contrast-enhanced breast MRI
-
Seoul, Jongno-gu, Korea, Republic ofSeoul National University Hospital
Feb 25, 2022
Digital Breast Tomosynthesis to Improve Assessment of Resection
Completed
- Invasive Breast Cancer
- +2 more
-
Aarhus, Danmark, DenmarkDepartment og Plastic- and Breast Surgery
Feb 16, 2022
Breast Carcinoma, Metastatic Breast Cancer, Invasive Breast Cancer Trial in Obninsk (Device: Radiation: Diffusing Alpha
Recruiting
- Breast Carcinoma
- +3 more
- Device: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
-
Obninsk, Kaluga Region, Russian FederationA. Tsyb Medical Radiological Research Center
Feb 16, 2022
Triple Negative Breast Cancer, Vitamin D Deficiency, Invasive Breast Cancer Trial in Winston-Salem (drug, dietary supplement,
Recruiting
- Triple Negative Breast Cancer
- +2 more
- Standard of Care Neoadjuvant Chemotherapy
- +2 more
-
Winston-Salem, North CarolinaWake Forest Baptist Health Sciences
Feb 8, 2022
Breast Cancer Genome Guided Therapy Study (BEAUTY)
Active, not recruiting
- Invasive Breast Cancer
-
Scottsdale, Arizona
- +1 more
Jan 5, 2022
Invasive Breast Cancer Trial in Madison ([18F]Fluorofuranylnorprogesterone (FFNP) PET/MR Imaging)
Recruiting
- Invasive Breast Cancer
- [18F]Fluorofuranylnorprogesterone (FFNP) PET/MR Imaging
-
Madison, WisconsinUniversity of Wisconsin, Madison
Dec 16, 2021
Invasive Breast Cancer Trial in Iowa City (Vandetanib, Placebo)
Terminated
- Invasive Breast Cancer
- Vandetanib
- Placebo
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Oct 1, 2021